Synapse - Jae Park

Search Within

Jae Hong Park

Results (389)

Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)

Meeting Abstract

Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Outcomes of patients 60 and older with ALL: Analysis of the SEER database

Meeting Abstract

Geyer, M. B.; Hsu, M.; Devlin, S.; Douer, D.; Park, J. H.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Updated results: Phase I trial of autologous CD19-targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy

Meeting Abstract

Geyer, M. B.; Park, J. H.; Riviere, I.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. J.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Implications of concurrent ibrutinib therapy on CAR T-cell manufacturing and phenotype and on clinical outcomes following CD19-targeted CAR T-cell administration in adults with relapsed/refractory CLL

Meeting Abstract

Geyer, M. B.; Park, J. H.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T. J.; Sadelain, M. W.; Brentjens, R. J.
Blood (2016)

Fulltext@MSK | Save

A pediatric-inspired regimen containing multiple doses of intravenous pegylated asparaginase appears safe and effective in newly diagnosed adult patients with Ph-negative acute lymphoblastic leukemia in adults up to age 60: Results of a multi-center phase II clinical trial

Meeting Abstract

Park, J. H.; Ritchie, E. K.; Rao, A. V.; Devlin, S.; Hsu, M.; Khawaja, T. T.; O'Donnell, B. A.; Cazacu, M. I.; Stopka, D. M.; Tallman, M. S.; more...
Blood (2016)

Fulltext@MSK | Save

Impact of treatment center characteristics on early death rates in patients with newly diagnosed acute promyelocytic leukemia: Analysis of data from the SEER program

Meeting Abstract

Park, J. H.; Devlin, S.; Lynch, C.; Schwartz, A.; Keegan, T.; Gonsalves, L.; Hermit, K.; Green, M.; Douer, D.; Tallman, M. S.
Blood (2016)

Fulltext@MSK | Save

Phase I trial of targeted alpha-particle therapy with Actinium-225 ((225)Ac)-lintuzumab and low-dose cytarabine (LDAC) in patients age 60 or older with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Levy, M. Y.; Park, J. H.; Ravandi, F.; Perl, A. E.; Pagel, J. M.; Smith, B. D.; Estey, E. H.; Kantarjian, H.; Cicic, D.; more...
Blood (2016)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia

Meeting Abstract

Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
Blood (2016)

Fulltext@MSK | Save

Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies

Meeting Abstract

He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
Blood (2016)

Fulltext@MSK | Save

A distributed international patient data registry for hairy cell leukemia

Meeting Abstract

Andritsos, L. A.; Grever, M. R.; Anghelina, M.; Dearden, C. E.; Else, M.; Blachly, J. S.; Lele, O.; Ravandi, F.; Zent, C. S.; Johnston, J. B.; more...
Blood (2016)

Fulltext@MSK | Save